Literature DB >> 11782589

Cellular immune response in HIV-infected patients with histoplasmosis.

G Matthew Vail1, Satish Mocherla, L Joseph Wheat, Janet Goldberg, April Camp, Edward Brizendine, Carol Schnizlein-Bick.   

Abstract

The relationship of immunity to Histoplasma capsulatum and CD4 count in HIV-1-infected patients is unknown. Samples of blood from people with HIV infection and from HIV-negative volunteers were assessed for immune responsiveness to the histoplasmin antigen using proliferation and interferon-gamma production as indicators of immunity. Results of histoplasmin skin tests, lymphoproliferative responses (LPR), and interferon-gamma production were positive in 9 of 20 (45%) HIV-negative controls, and in vitro measurements agreed highly with skin test reactivity. Among HIV-1-infected patients with recent histoplasmosis, skin test results were positive in none, LPR results were positive in 14%, and interferon-gamma production in 18%. Among HIV-1-infected patients with CD4 counts between 200 and 500 cells/mm(3), LPR was positive in 8% and interferon-gamma production in 33%, and among those with CD4 counts >500 cells/mm(3), LPR was positive in 31% and interferon-gamma production in 46%. In conclusion, immune responsiveness to H. capsulatum was depressed in HIV-1-infected persons with CD4 counts between 200 and 500 cells/mm(3), but approached normal in those with CD4 counts >500 cells/mm(3).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11782589     DOI: 10.1097/00126334-200201010-00006

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  1 in total

1.  Diagnostic value of culture and serological tests in the diagnosis of histoplasmosis in HIV and non-HIV Colombian patients.

Authors:  Karen Arango-Bustamante; Angela Restrepo; Luz Elena Cano; Catalina de Bedout; Angela Maria Tobón; Angel González
Journal:  Am J Trop Med Hyg       Date:  2013-09-16       Impact factor: 2.345

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.